NCT06216444View on ClinicalTrials.gov

A Study of Remimazolam Tosilate for Sedation in Non-intubated Diagnostic and Therapeutic Procedures

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Sedation in Non-intubated Diagnostic and Therapeutic Procedures
Interventions
DRUG

Remimazolam Tosilate for Injection

Initial loading dose of 5mg, with additional doses of 2.5mg as necessary

DRUG

Remimazolam Tosilate for Injection

Initial loading dose of 10mg, with additional doses of 2.5mg as necessary

Trial Locations (1)

200032

Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT06216444 - A Study of Remimazolam Tosilate for Sedation in Non-intubated Diagnostic and Therapeutic Procedures | Biotech Hunter | Biotech Hunter